A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine
about
Quantity and Quality of Inhaled Dose Predicts Immunopathology in TuberculosisStrategies to potentiate antimicrobial photoinactivation by overcoming resistant phenotypesStructural and functional analysis of the transcriptional regulator Rv3066 of Mycobacterium tuberculosisMycobacterium tuberculosis Transcription Machinery: Ready To Respond to Host AttacksThe antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosisNew Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in MycobacteriaReduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis.Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs.Sterilizing activity of thioridazine in combination with the first-line regimen against acute murine tuberculosis.The stress-response factor SigH modulates the interaction between Mycobacterium tuberculosis and host phagocytesLatent tuberculosis infection: myths, models, and molecular mechanismsThe HtrA-like serine protease PepD interacts with and modulates the Mycobacterium tuberculosis 35-kDa antigen outer envelope protein.DNA methylation impacts gene expression and ensures hypoxic survival of Mycobacterium tuberculosis.The Mycobacterium tuberculosis Clp gene regulator is required for in vitro reactivation from hypoxia-induced dormancy.DNA, cell wall and general oxidative damage underlie the tellurite/cefotaxime synergistic effect in Escherichia coli.The Mycobacterium tuberculosis Rv2745c plays an important role in responding to redox stress.ClpR protein-like regulator specifically recognizes RecA protein-independent promoter motif and broadly regulates expression of DNA damage-inducible genes in mycobacteria.Global analyses of TetR family transcriptional regulators in mycobacteria indicates conservation across species and diversity in regulated functionsDrug-resistant tuberculosis: emerging treatment options.In-Vivo Gene Signatures of Mycobacterium tuberculosis in C3HeB/FeJ Mice.The Mycobacterium tuberculosis stress response factor SigH is required for bacterial burden as well as immunopathology in primate lungs.Global Transcriptomic Analysis of the Response of Corynebacterium glutamicum to Vanillin.Hypoxia Sensing and Persistence Genes Are Expressed during the Intragranulomatous Survival of Mycobacterium tuberculosis.MprAB regulates the espA operon in Mycobacterium tuberculosis and modulates ESX-1 function and host cytokine response.Thioridazine lacks bactericidal activity in an animal model of extracellular tuberculosis.Rv2744c Is a PspA Ortholog That Regulates Lipid Droplet Homeostasis and Nonreplicating Persistence in Mycobacterium tuberculosis.The role of transport mechanisms in mycobacterium tuberculosis drug resistance and tolerance.Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them.A novel molecular typing method of Mycobacteria based on DNA barcoding visualization.Why and How the Old Neuroleptic Thioridazine Cures the XDR-TB Patient.Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of Action.Why and how thioridazine in combination with antibiotics to which the infective strain is resistant will cure totally drug-resistant tuberculosis.Unveiling the mechanisms for decreased glutathione in individuals with HIV infection.A novel pathway producing dimethylsulphide in bacteria is widespread in soil environments.Triclosan-induced genes Rv1686c-Rv1687c and Rv3161c are not involved in triclosan resistance in Mycobacterium tuberculosis.Suramin is a potent and selective inhibitor of Mycobacterium tuberculosis RecA protein and the SOS response: RecA as a potential target for antibacterial drug discovery.Control of Mycobacterium tuberculosis growth by activated natural killer cells.Evidence of significant synergism between antibiotics and the antipsychotic, antimicrobial drug flupenthixol.
P2860
Q26801645-8A5E15DF-3541-4539-9BD5-265BF3DFC774Q27027057-33BC28CB-34D5-4E83-B699-2A065DF51E29Q27670866-AB641070-C39F-4821-B660-663E15E1522BQ28071015-5A39022C-CEDC-4964-BF48-1481A4520F48Q28475461-554265AC-B862-4B8C-92BE-4D3B1D1B7F77Q33600161-8CFB9F6D-9B68-451C-B401-A006537DB56EQ33798280-54F12B78-1011-4EE5-8226-EC6E0D1F4692Q33947806-7DCB2297-F8AD-4941-BD35-25A74D11BC90Q34057500-4FD00BE3-EA3D-41B0-83BF-D4CD6358D097Q34123517-F70479A0-6ADF-43EA-BBED-273C6CDCF093Q34297816-E1A5E1C8-27F9-4034-9920-5AFE02EE0F57Q34708329-E8A75724-E53C-4BDF-AE7A-92D16658315AQ34819430-1909CF06-4511-43EA-ABD4-36C1FE793D8BQ35002980-C5E79848-4DA3-46C8-B38B-E44823B48CB8Q35048486-48CF40CC-1F43-415C-A9CF-AB68313DC56BQ35140367-FBFFA7FE-9B96-4173-A46C-362842C32C7CQ35213214-61C3779A-A8EC-43C3-8E50-CD7C258F3AB6Q35675954-256330C6-20B0-4CE5-8B10-AB44A7A88395Q35683967-F9E4D2EF-A180-4390-84DF-679925B7E2C0Q35744854-42DDF417-3B2D-4D49-A081-405C42D7270DQ35842269-448C89A5-EDFF-499D-AD4A-6ACFC789DCB8Q36168012-CD3C4E4A-D71F-4C21-8AF5-F01FBE3395ABQ36264025-A3041848-8B7C-4908-9F68-E39E88D17002Q36506250-EFA2CAA6-7A11-44C0-A16A-A1D4786AE48FQ36844672-9FF72095-0D71-4B20-92CC-C67EB57E4F01Q37122532-8BD78070-CFEA-44DA-B2C0-A6244AB09849Q37277325-B8FFEF46-D6E2-4F2C-8DF0-9354026382DCQ37428456-68EA487B-01F6-4058-B485-0076F219661BQ37597904-A0C4E1C5-E2CA-4949-AAF9-2EDB959B6B6EQ38166534-DF36274C-0B12-4593-AA76-5369DF34EB5FQ38872058-887583E8-7A6F-44FC-BA67-8C76A236DDA7Q38872081-065887E3-EDFF-4C97-965A-6788E4E3C647Q40255209-FFEDB67F-CF15-458E-BB3F-BFE7019E983CQ41164117-8DB0FDF6-5EBE-490C-AD5B-AE38EAA7E541Q42046889-2E5FF998-1ED8-4446-AE16-F125BD94D494Q43633453-5146F388-29A2-432F-910D-DAD3644C9116Q44028839-E0DEB36A-550B-4ACE-8566-4A9165204179Q50035189-4D6CB1CD-3FEC-4E8D-A85B-57706D14BCDB
P2860
A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A Mycobacterium tuberculosis s ...... nti-mycobacterial thioridazine
@ast
A Mycobacterium tuberculosis s ...... nti-mycobacterial thioridazine
@en
A Mycobacterium tuberculosis s ...... nti-mycobacterial thioridazine
@nl
type
label
A Mycobacterium tuberculosis s ...... nti-mycobacterial thioridazine
@ast
A Mycobacterium tuberculosis s ...... nti-mycobacterial thioridazine
@en
A Mycobacterium tuberculosis s ...... nti-mycobacterial thioridazine
@nl
prefLabel
A Mycobacterium tuberculosis s ...... nti-mycobacterial thioridazine
@ast
A Mycobacterium tuberculosis s ...... nti-mycobacterial thioridazine
@en
A Mycobacterium tuberculosis s ...... nti-mycobacterial thioridazine
@nl
P2860
P3181
P1433
P1476
A Mycobacterium tuberculosis s ...... nti-mycobacterial thioridazine
@en
P2093
Deepak Kaushal
Smriti Mehra
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0010069
P407
P577
2010-04-08T00:00:00Z